[HTML][HTML] A review of anti-VEGF agents for proliferative diabetic retinopathy
P Osaadon, XJ Fagan, T Lifshitz, J Levy - Eye, 2014 - nature.com
Previous research has implicated vascular endothelial growth factor (VEGF) in the
pathogenesis of diabetic retinopathy (DR). Although many studies reviewed the use of anti …
pathogenesis of diabetic retinopathy (DR). Although many studies reviewed the use of anti …
Anti–vascular endothelial growth factor agents in the treatment of retinal disease: from bench to bedside
The association of retinal hypoxia with retinal neovascularization has been recognized for
decades, causing Michaelson to postulate in 1948 that a factor secreted by hypoxic retina …
decades, causing Michaelson to postulate in 1948 that a factor secreted by hypoxic retina …
Antiangiogenic therapy for ischemic retinopathies
Neovascularization is a common pathological process in various retinal vascular disorders
including diabetic retinopathy (DR), age-related macular degeneration (AMD) and retinal …
including diabetic retinopathy (DR), age-related macular degeneration (AMD) and retinal …
Treatment of diabetic retinopathy with anti‐VEGF drugs
M Waisbourd, M Goldstein… - Acta …, 2011 - Wiley Online Library
The aim of this review is to summarize the latest developments in the treatment of diabetic
retinopathy (DR) with anti‐vascular endothelial growth factor (VEGF) drugs. We reviewed …
retinopathy (DR) with anti‐vascular endothelial growth factor (VEGF) drugs. We reviewed …
CD160 protein as a new therapeutic target in a battle against autoimmune, infectious and lifestyle diseases. Analysis of the structure, interactions and functions
M Piotrowska, M Spodzieja, K Kuncewicz… - European journal of …, 2021 - Elsevier
The glycosylphosphatidylinositol-anchored transmembrane glycoprotein CD160 (cluster of
differentiation 160) is a member of the immunoglobulin superfamily. Four isoforms, which …
differentiation 160) is a member of the immunoglobulin superfamily. Four isoforms, which …
OCT angiography-based monitoring of neovascular regression on fibrovascular membrane after preoperative intravitreal conbercept injection
Z Hu, Y Su, P Xie, L Chen, J Ji, T Feng, S Wu… - Graefe's Archive for …, 2019 - Springer
Purpose To quantify the preoperative neovascular change pattern on the fibrovascular
membrane (FVM) within 7 days after intravitreal injection of conbercept (IVC) using optical …
membrane (FVM) within 7 days after intravitreal injection of conbercept (IVC) using optical …
[HTML][HTML] Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α
XX Han, CM Guo, Y Li, YN Hui - Molecular vision, 2012 - ncbi.nlm.nih.gov
Purpose Anti-vascular endothelial growth factor (VEGF) agents have recently been used
intravitreally during the perioperative period for proliferative diabetic retinopathy (PDR) …
intravitreally during the perioperative period for proliferative diabetic retinopathy (PDR) …
[HTML][HTML] Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous …
FI Shakarchi, AF Shakarchi… - Clinical Ophthalmology …, 2019 - ncbi.nlm.nih.gov
Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without
macular edema treated initially with intravitreous bevacizumab - PMC Back to Top Skip to …
macular edema treated initially with intravitreous bevacizumab - PMC Back to Top Skip to …
糖尿病视网膜病变药物治疗的研究进展
蒲一民， 杨君， 杨田 - 国际眼科杂志, 2011 - cqvip.com
糖尿病视网膜病变(diabetic retinopathy, DR) 是糖尿病患者常见和严重的并发症之一,
是糖尿病患者视力损害的最主要原因. 随着对糖尿病发病机制的深入研究, 近年来多种药物用于 …
是糖尿病患者视力损害的最主要原因. 随着对糖尿病发病机制的深入研究, 近年来多种药物用于 …
Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy
X Zhang, W Yu, F Dong - Graefe's Archive for Clinical and Experimental …, 2012 - Springer
Background To investigate the role of CYR61 as a retinal angiogenic factor in proliferative
diabetic retinopathy (PDR). Methods Effects of CYR61 on RF/6A cell proliferation, migration …
diabetic retinopathy (PDR). Methods Effects of CYR61 on RF/6A cell proliferation, migration …